Skip to main content
Log in

Serum kinetics of doxycycline polyphosphate in dogs

  • Original Papers
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Serum kinetics of Doxycycline polyphosphate (DPP) have been studied in dogs after oral administration of 10 mg.kg−1 by measurement of total serum concentration (Ct) of tetracycline derivatives by a chemical assay and active concentration (Ca) by a microbiological method.

Kinetics have been studied using a one compartment open model with absorption by oral route.

DPP is rapidly absorbed, the peak serum level is reached three hours after absorption and slowly eliminated (elimination half-life =12 hours).

The main differences observed between Ct and Ca kinetics are in the values of the areas under the curves (AUC) and the peak serum level. The values obtained for these parameters for Ca kinetics were found to be 50% of those obtained for Ct, the volumes of distribution being in inverse proportion.

These results are in a good agreement with the correlation and linear regression observed between Ca and Ct showing that 55% of total serum Doxycycline possesses immediate antibacterial activity. It is postulated that this difference between Ct and Ca kinetics is essentially a reflection of the ratios of bound and free drug.

Similar results were obtained with the finished pharmaceutical form except for a 15% increase of AUC indicating improvement of the bioavailability of the drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Neuvonen P.J. (1976): Drugs, Interactions with the absorption of tetracyclines,11, 45–54.

    Article  CAS  PubMed  Google Scholar 

  2. Forsgren A. and Gnarpe H. (1973): Antimicrob. Agents and Chemother., Tetracyclines and host-defense mechanisms,3, 6, 711–715.

    CAS  Google Scholar 

  3. Forsgren A. and Gnarpe H. (1973): Nature New Biology, Tetracycline interference with the bactericidal effect of serum,244, 133, 82–83.

    CAS  PubMed  Google Scholar 

  4. Arcilla J.D., Fiore J.L., Resnick O., Nadelmann J.W., Huth J.L. and Troetel W.M. (1974): Curr. Ther. Res., Comparative bioavailability of doxycycline,16, 10, 1126–1136.

    CAS  PubMed  Google Scholar 

  5. Welling P.G., Koch P.A., Lau C.C. and Craig W.A. (1977): Antimicrobial Agents Chemother., Bioavailability of tetracycline and doxycycline in fasted and nonfasted subjects,11, 462–469.

    CAS  Google Scholar 

  6. Kohn K.W. (1961): Anal. Chem., Determination of tetracyclines by extraction of fluorescent complexes — Application to biological materials,33, 7, 862–866.

    Article  CAS  Google Scholar 

  7. Bennet J.V., Brodie J.L., Benner E.J. and Kirby W.M.M. (1966): Appl. Microbiol. Simplified accurate method for antibiotic assay on clinical specimens,14, 170–177.

    Google Scholar 

  8. Wagner J.G. (1967): Clin. Pharmacol. Ther., Use of computers in pharmacokinetics,8, 201–218.

    CAS  PubMed  Google Scholar 

  9. Jaffe J.M., Poust R.I., Felds S.L. and Colaizzi J.L. (1974): J. Pharm. Sci., Influence of repetitive dosing and altered urinary pH on doxycycline excretion in humans,63, 8, 1256–1260.

    Article  CAS  PubMed  Google Scholar 

  10. Mahon W.A., Johnson G.E., Endrenyl L., Kelly M.F. and Fenton S.S.A. (1976): Scand. J. Infect. Dis., The elimination of tritiated doxycycline in normal subjects and in patients with severely impaired renal function,9, 24–31.

    CAS  Google Scholar 

  11. Modr Z., Dvorzhachek K., Shmidt O. and Nechaskova A. (1974): Antibiotiki, Pharmacokinetics of doxycycline on its repeated oral administration,19, 12, 1063–1067.

    CAS  PubMed  Google Scholar 

  12. Fabre J., Pitton J.S., Virieux C, Daurencet F.L., Bernhardt J.P. and Godel J.C. (1967): Schweiz. med. Wschr., La doxycycline: absorption, distribution et excrétion d’un nouvel antibiotique à large spectre chez l’homme,97, 28, 915–924.

    CAS  PubMed  Google Scholar 

  13. Von Wittenau M.S. and Twomey T.M. (1971): Chemotherapy, The disposition of doxycycline by man and dog,16, 217–228.

    Article  Google Scholar 

  14. Tillement J.P. et Chauvelot L. (1978): Thérapie, Antibiotiques et fixation protéique,33, 3, 235–249.

    CAS  PubMed  Google Scholar 

  15. Fourtillan J.B. et Saux M.Cl. (1978): Sem. Hop. PARIS, Intérêt des tétracyclines de deuxième génération. Comportement pharmacocinétique,54, 4, 224–230.

    CAS  PubMed  Google Scholar 

  16. Green R.G., Brown J.R. and Calvert R.T. (1976): J. Pharm. Pharmac, Estimation of the degree of binding of tetracyclines in human plasma,28, 514–515.

    CAS  Google Scholar 

  17. Kunin C.M., Craig W.A., Kornguth M. and Monson R. (1973): Ann. N.Y. Acad. Sci., Influence of binding on the pharmacologic activity of antibiotics,226, 214–224.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Michel, G., Mosser, J. & Fauran, F. Serum kinetics of doxycycline polyphosphate in dogs. European Journal of Drug Metabolism and Pharmacokinetics 4, 43–48 (1979). https://doi.org/10.1007/BF03189398

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189398

Key-words

Navigation